secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tarsus Pharmaceuticals, Inc. (TARS)
CIK:        0001819790
Form:       8-K
Filed at:   2022-06-22T23:59:59+00:00
Accession:  0001193125-22-178792
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tarsus shareholders elect 4 Class II directors, ratify E&Y as auditor at annual meeting
--------------------------------------------------------------------------------

- Votes for nominees: Ackermann 10.09M, Azamian 10.22M, Crane 11.04M, Yeu-Lin 10.91M; ~4.27M broker non-votes each.
- Ratification of Ernst & Young as auditor approved with 15.32M votes for, 1,027 against, 37 abstain.
- Four incumbent directors continue: Link, Chaudhuri, Goldberg, Yarno.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819790/000119312522178792/0001193125-22-178792-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819790/000119312522178792/d301085d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-178792

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer